Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Altimmune Inc (NQ: ALT )

4.600 +1.440 (+45.57%)
Streaming Delayed Price Updated: 10:44 AM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,653,942
Open 5.740
Bid (Size) 4.590 (32)
Ask (Size) 4.600 (3)
Prev. Close 3.160
Today's Range 4.110 - 5.860
52wk Range 2.090 - 17.17
Shares Outstanding 53,728,871
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
Software earnings were strong, while the Fed is shifting toward rate cuts. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower
Altimmune Inc (NASDAQ: ALT) announced topline results from its 48-week MOMENTUM Phase 2 obesity trial of pemvidutide  
Via Benzinga

Performance

YTD
-70.57%
-70.57%
1 Month
+90.87%
+90.87%
3 Month
+81.82%
+81.82%
6 Month
+12.61%
+12.61%
1 Year
-53.77%
-53.77%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Altimmune's Earnings Outlook
Via Benzinga
Preview: Altimmune's Earnings
Via Benzinga
Altimmune: Q1 Earnings Insights
Via Benzinga
Earnings Preview: Altimmune
Via Benzinga
Short Volatility Alert: Altimmune Inc
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
7 Analysts Have This to Say About Altimmune
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
Via Benzinga
Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It
Via Benzinga
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
Via InvestorPlace
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Cheap Stocks That Are Worth Your Attention
Via InvestorPlace
BioRestorative Therapies (NASDAQ: BRTX) Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion
Via Benzinga
Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%?
Via The Motley Fool
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.